Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Healthtrust
US Department of Justice
Dow
McKesson
Chubb
Express Scripts
Deloitte

Generated: April 19, 2018

DrugPatentWatch Database Preview

CELONTIN Drug Profile

« Back to Dashboard

When do Celontin patents expire, and what generic alternatives are available?

Celontin is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in CELONTIN is methsuximide. One supplier is listed for this compound. Additional details are available on the methsuximide profile page.
Drug patent expirations by year for CELONTIN
Synonyms for CELONTIN
.alpha.-Methyl-.alpha.-phenyl N-methyl succinimide
.alpha.-Methylphensuximide
(+-)-N,2-Dimethyl-2-phenylsuccinimide
(+/-)-Mesuximide
(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion
077M418
1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine
1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione
1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione #
1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione
1,3-Dimethyl-3-phenyl-pyrrolidine-2,5-dione
1,3-dimethyl-3-phenylpyrrolidine-2,5-dione
1,3-Dimethyl-3-phenylsuccinimide
2,5-Pyrrolidinedione, 1,3-dimethyl-3-phenyl-
2,5-Pyrrolidinedione,1,3-dimethyl-3-phenyl-
2,5-Pyrrolidinedione,1,3-dimethyl-3-phenyl-, (+-)-
5-21-11-00209 (Beilstein Handbook Reference)
77-41-8
AB01563316_01
AC-15963
AC1L1MM3
AC1Q3XU0
ACM1189980639
AJXPJJZHWIXJCJ-UHFFFAOYSA-N
AKOS015962173
alpha-Methyl-alpha-phenyl N-methyl succinimide
alpha-Methylphensuximide
AN-23910
API0001928
BC209799
BRN 0168315
C12H13NO2
CAS-77-41-8
CCG-213444
Celontin (TN)
CHEBI:6846
CHEMBL697
CTK8E3125
D00404
D08EOD
DB05246
DSSTox_CID_3293
DSSTox_GSID_23293
DSSTox_RID_76960
DTXSID5023293
EINECS 201-026-7
FT-0671397
GTPL7228
HE043878
HE300416
HE387892
HMS3264P21
HSDB 3124
LS-147580
mesuximid
Mesuximida
Mesuximida [INN-Spanish]
Mesuximide
Mesuximide (INN)
Mesuximide [INN]
Mesuximidum
Mesuximidum [INN-Latin]
Methsuximid
METHSUXIMIDE
Methsuximide (USP)
Methsuximide [BAN]
Methsuximide [USP]
Methsuximide/ 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione/ 1,3-Dimethyl-3-phenylsuccinimide/ PM 396
Metosuccimmide
Metosuccimmide [DCIT]
Metsuccimide
MFCD00072132
MolPort-003-666-689
N-Methyl-.alpha.-methyl-.alpha.-phenylsuccinimide
N-Methyl-.alpha.,.alpha.-methylphenylsuccinimide
N-Methyl-alpha-methyl-alpha-phenylsuccinimide
N,2-Dimethyl-2-phenylsuccinimide
NCGC00189077-01
NSC-760075
NSC760075
Petinutin
Petinutin (TN)
Pharmakon1600-01505443
PM 396
racemic methsuximide
SCHEMBL34852
SR-01000942246
SR-01000942246-1
Succinimide, N,2-dimethyl-2-phenyl-
Tox21_113613
TX-015841

US Patents and Regulatory Information for CELONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis CELONTIN methsuximide CAPSULE;ORAL 010596-007 Approved Prior to Jan 1, 1982 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parke Davis CELONTIN methsuximide CAPSULE;ORAL 010596-008 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Deloitte
Covington
Healthtrust
Accenture
UBS
Medtronic
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.